Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson ( JNJ )

The 3 Top ETFs to Purchase in 2023

With less aggressive but drawn-out interest rate hikes by the Fed visibly slowing down an otherwise robust economy, the stock market is expected to remain volatile in the foreseeable future. Hence, it would be wise to invest in Vanguard Value ETF (VTV), iShares Russell 1000 Value ETF (IWD), and Energy…

StockNews.com

1 Stable Stock to Put on Your Buy List Now

With the Fed’s progressive interest-rate hikes keeping markets in perpetual turmoil, strong fundamentals of Johnson & Johnson (JNJ) could help investors secure decent risk-adjusted returns on their investments. Read on….

StockNews.com

3 Top Health Care ETFs to Buy and Hold for the Long Haul

Given the inelastic demand for healthcare goods and services, the industry experiences stable growth in any economic situation. Moreover, lucrative federal funding is expected to boost the sector. Therefore, quality healthcare ETFs Vanguard Health Care Index Fund (VHT), Invesco S&P 500 Equal Weight Health Care ETF (RYH), and VanEck Pharmaceutical…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

4 Pharmaceutical Stocks You Can Always Rely On

The pharmaceutical industry is well-positioned to witness substantial growth, driven by the prevalence of chronic diseases, the aging population, and increased healthcare spending. Given the industry’s promising growth prospects, we think it could be wise to invest in fundamentally sound pharmaceutical stocks Johnson & Johnson (JNJ), Merck & Co (MRK),…

StockNews.com

3 Stocks Seasoned Investors on Wall Street Love to Buy

The Fed might be on course to trigger market volatility with another interest rate hike next month. With an end to the Fed’s campaign on inflation through rate hikes nowhere in sight, it would be wise to invest in resilient stocks Microsoft (MSFT), Johnson & Johnson (JNJ), and Coca-Cola (KO),…

StockNews.com

3 Health Care Stocks That Are No-Brainer Buys Right Now

The healthcare industry is expected to witness significant growth in the foreseeable future, driven by rising health awareness, an aging population, and increasing chronic diseases worldwide. Furthermore, the healthcare industry is known to perform steadily regardless of economic conditions because of the inelastic demand for healthcare products and services. Therefore,…

StockNews.com

3 Stocks to Help You Grow the Nest Egg

The S&P 500 and the Nasdaq closed the last week lower, ending the four-week winning streak on concerns over the hawkish Fed and weak economic data of some of the influential countries. However, investors should consider fundamentally sound growth stocks The Kroger (KR), Johnson & Johnson (JNJ), and Taiwan Semiconductor…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Large-Cap Healthcare Stocks to Buy for Bigger Gains

Due to the inelastic demand and rising investments, the healthcare sector is witnessing investor confidence amid these uncertain market conditions. Although persistent macroeconomic headwinds might affect stocks in this space, investors could consider buying dividend-paying large-cap stocks Johnson & Johnson (JNJ), Merck & Co (MRK), and UnitedHealth Group (UNH) to…

StockNews.com

Here's Why Every Investor Might Want to Buy Shares of JNJ

Including dividends, Johnson & Johnson (JNJ) has delivered exceptional returns over the past decade. Given the company’s robust financials, strong dividend-paying history, solid growth prospects, and higher-than-industry profitability, the stock could be an excellent investment amid the current uncertain market conditions. Read on….

StockNews.com

Will Johnson & Johnson Continue Trending Higher This Year?

The COVID-19 pandemic has given a boost to the pharmaceutical industry's revenues. And pharmaceutical companies are expected to remain in focus by investors as the demand for medicines rises with an increase in lifestyle-related ailments and a rapidly aging global population. So, given the industry’s favorable tailwinds, its robust financials…

StockNews.com

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

595 stories

Santanu RoyHaving

215 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

Berkshire Hathaway Inc

Medical – Pharmaceuticals

69 stories

Johnson

66 stories

CVS Health Corporation

61 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.